Many clinicians have to make critical blood therapy decisions based on the limited snapshots provided by traditional tests – tests that simply weren’t designed to provide them with the timely, relevant and comprehensive results they need (1-4). Effective hemostasis management requires that physicians have the most complete information to make decisions on how to best maintain and/or restore a patient’s coagulation equilibrium.
Literature and ongoing trials have shown by adding the TEG® Hemostasis Analyzer System to your clinical practice and blood management program, you can help predict and manage coagulopathy (3-8), help assess the risk for re-operation (9-10), and realize cost savings through the reduction of unnecessary blood component transfusions (10-11).
Please select your language.
International English (OUS) and other languages direct you to websites for our products which are NOT intended for use in the United States.
Please select United States (English) for products cleared for sale and use in the United States.